These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 22622559)

  • 21. The US Food and Drug Administration and probiotics: regulatory categorization.
    Degnan FH
    Clin Infect Dis; 2008 Feb; 46 Suppl 2():S133-6; discussion S144-51. PubMed ID: 18181719
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Considerations in the development of live biotherapeutic products for clinical use.
    Ross JJ; Boucher PE; Bhattacharyya SP; Kopecko DJ; Sutkowski EM; Rohan PJ; Chandler DK; Vaillancourt J
    Curr Issues Mol Biol; 2008; 10(1-2):13-6. PubMed ID: 18525102
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Marketing drugs too early in testing.
    Begg CB; Brawley O; Califf RM; Demets DL; Ellenberg SS; Kaplan RS
    Science; 2006 Apr; 312(5771):195. PubMed ID: 16614197
    [No Abstract]   [Full Text] [Related]  

  • 24. The Food and Drug Administration and patent law at a crossroads: the listing of polymorph patents as a barrier to generic drug entry.
    Srivastava D
    Food Drug Law J; 2004; 59(2):339-54. PubMed ID: 15298015
    [No Abstract]   [Full Text] [Related]  

  • 25. Between a rock and a hard place.
    Demaria AN
    J Am Coll Cardiol; 2010 Nov; 56(21):1761-2. PubMed ID: 21070930
    [No Abstract]   [Full Text] [Related]  

  • 26. The FDA's accelerated approval process: does the pharmaceutical industry have adequate incentives for self-regulation?
    Orlando VI
    Am J Law Med; 1999; 25(4):543-68. PubMed ID: 10629734
    [No Abstract]   [Full Text] [Related]  

  • 27. Moment of reckoning.
    Wadman M
    Nature; 2007 Apr; 446(7138):844-5. PubMed ID: 17443154
    [No Abstract]   [Full Text] [Related]  

  • 28. Off-label drug use.
    Dooley AG
    Med Health R I; 2007 Feb; 90(2):63-5. PubMed ID: 17500258
    [No Abstract]   [Full Text] [Related]  

  • 29. Competitors try collaboration to speed drug development.
    Patlak M
    J Natl Cancer Inst; 2010 Jun; 102(12):841-3. PubMed ID: 20530762
    [No Abstract]   [Full Text] [Related]  

  • 30. The fast track effect.
    Cohen FJ
    Nat Rev Drug Discov; 2004 Apr; 3(4):293-4. PubMed ID: 15124622
    [No Abstract]   [Full Text] [Related]  

  • 31. Accelerated approval and oncology drug development timelines.
    Lanthier ML; Sridhara R; Johnson JR; Farrell A; Keegan P; Justice R; Pazdur R
    J Clin Oncol; 2010 May; 28(14):e226-7; author reply e228. PubMed ID: 20194846
    [No Abstract]   [Full Text] [Related]  

  • 32. FDA notifications. New pediatric guidelines by NIH, CDC.
    AIDS Alert; 2009 Oct; 24(10):117-8. PubMed ID: 20034139
    [No Abstract]   [Full Text] [Related]  

  • 33. Cancer drug approval in the United States, Europe, and Japan.
    Milsted RA
    Adv Cancer Res; 2007; 96():371-91. PubMed ID: 17161686
    [No Abstract]   [Full Text] [Related]  

  • 34. Impact of new regulations for pediatric labeling by the Food and Drug Administration.
    Buck ML
    Pediatr Nurs; 2000; 26(1):95-6. PubMed ID: 12026326
    [No Abstract]   [Full Text] [Related]  

  • 35. Re: Clinical trials registration efforts gain some ground.
    Manrow RE
    J Natl Cancer Inst; 2005 Jun; 97(12):936. PubMed ID: 15956658
    [No Abstract]   [Full Text] [Related]  

  • 36. The FDA and "privatization"--the drug approval process.
    Rutherford EM
    Food Drug Law J; 1995; 50 Spec():203-25. PubMed ID: 10343044
    [No Abstract]   [Full Text] [Related]  

  • 37. Progress and deficiencies in the registration of clinical trials.
    Wood AJ
    N Engl J Med; 2009 Feb; 360(8):824-30. PubMed ID: 19228628
    [No Abstract]   [Full Text] [Related]  

  • 38. Generic drugs: the stalling game.
    Consum Rep; 2001 Jul; 66(7):36-40. PubMed ID: 11725791
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Roadmap for revitalization?
    Nat Biotechnol; 2007 Oct; 25(10):1061. PubMed ID: 17921973
    [No Abstract]   [Full Text] [Related]  

  • 40. Food and drug administration expanded access to treatment: implications for oncology patients.
    Freedman RS; Markman M
    Cancer; 2007 Jun; 109(11):2157-60. PubMed ID: 17450587
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.